Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía Fernández, Saínza
dc.contributor.authorAlberich, Susana ORCID
dc.contributor.authorMartínez Cengotitabengoa, Mónica ORCID
dc.contributor.authorArango, Celso
dc.contributor.authorCastro-Fornieles, Josefina
dc.contributor.authorBaeza, Inmaculada
dc.contributor.authorMoreno, Carmen
dc.contributor.authorMicó, Juan Antonio
dc.contributor.authorBerrocoso, Esther
dc.contributor.authorGraell, Montserrat
dc.contributor.authorOtero, Soraya
dc.contributor.authorSimal, Tatiana
dc.contributor.authorGonzález Pinto Arrillaga, Ana María ORCID
dc.date.accessioned2018-12-11T11:23:50Z
dc.date.available2018-12-11T11:23:50Z
dc.date.issued2018-04-26
dc.identifier.citationPLOS ONE 13(4) : (2018) // Article ID e0194685es_ES
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10810/30247
dc.description.abstractOxidative stress is a pathophysiological mechanism potentially involved in psychiatric disorders. The objective of this study was to assess the relationship between total antioxidant status (TAS) and the functional status of patients with a first episode of psychosis at the onset of the disease. For this purpose, a sample of 70 patients aged between 9 and 17 years with a first episode of psychosis were followed up for a period of two years. Blood samples were drawn to measure TAS levels at three time points: at baseline, at one year, and at two years. Clinical symptoms and functioning were also assessed at the same time points using various scales. Linear regression analysis was performed to investigate the relationship between TAS and clinical status at each assessment, adjusting for potential confounding factors. The distribution of clinical variables was grouped in different percentiles to assess the dose-response in the relation between clinical variables and TAS. At baseline, patient's score on Children's Global Assessment Scale (CGAS) was directly and significantly associated with TAS with a monotonic increase in percentiles, and surprising this association was reversed after one and two years of follow-up with a monotonic decrease. In summary at the onset of the illness, TAS is positively related to clinical status, whereas as the illness progresses this correlation is reversed and becomes negative. This may be the result of an adaptive response.es_ES
dc.description.sponsorshipThis study has been funded by Instituto de Salud Carlos III through the projects PI14/01900, PI16/01164 (Co-funded by European Regional Development Fund/European Social Fund, "Investing in your future"); the Basque Foundation for Health Innovation and Research (BIOEF); Networking Center for Biomedical Research in Mental Health (CIBERSAM) and the University of the Basque Country (GIC12/84). The psychiatric research department in University Hospital Araba is supported by the Stanley Research Foundation (03-RC-003). Sainza Garcia has a PhD fellowship from the University of the Basque Country. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library Sciencees_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectoxidative stresses_ES
dc.subjectpsychiatric-disorderses_ES
dc.subjectin-vivoes_ES
dc.subjectschizophreniaes_ES
dc.subjectplasmaes_ES
dc.subjectpathophysiologyes_ES
dc.subjectinflammationes_ES
dc.subjectmarkerses_ES
dc.subjectbipolares_ES
dc.subjectscalees_ES
dc.titleThe complex association between the antioxidant defense system and clinical status in early psychosises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2018 García et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194685es_ES
dc.identifier.doi10.1371/journal.pone.0194685
dc.departamentoesFarmacia y ciencias de los alimentoses_ES
dc.departamentoesNeurocienciases_ES
dc.departamentoeuFarmazia eta elikagaien zientziakes_ES
dc.departamentoeuNeurozientziakes_ES


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2018 García et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Excepto si se señala otra cosa, la licencia del ítem se describe como © 2018 García et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.